Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Rite Aid to Close Over 100 Stores
Rite Aid is set to close more than 100 stores with efforts currently underway to try to sell dozens of stores across a dozen states.
Load More